UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 886

Sortiert nach

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.542-549

2006

Link zum Volltext

Verfügbarkeit prüfen

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Diabetologia, 2007-06, Vol.50 (6), p.1267-1276

2007

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

Journal of thrombosis and haemostasis, 2003-07, Vol.1 (7), p.1575-1579

2003

Link zum Volltext

Verfügbarkeit prüfen

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

International Journal of Obesity, 2012-03, Vol.36 (3), p.422-430

2012

Link zum Volltext

Verfügbarkeit prüfen

The CYP2C1917 allele is associated with better platelet response to clopidogrel in patients admitted for non‐ST acute coronary syndrome

Journal of thrombosis and haemostasis, 2009-08, Vol.7 (8), p.1409-1411

2009

Link zum Volltext

Verfügbarkeit prüfen

inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes

Diabetologia, 2009-06, Vol.52 (6), p.1152-1163

2009

Link zum Volltext

Verfügbarkeit prüfen

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study

Circulation (New York, N.Y.), 2004-03, Vol.109 (11), p.1343-1348

2004

Link zum Volltext

Verfügbarkeit prüfen

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

International Journal of Obesity, 2015-06, Vol.39 (6), p.977-985

2015

Link zum Volltext

Verfügbarkeit prüfen

Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.e533-e535

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study

Clinical genetics, 2017-01, Vol.91 (1), p.131-136

2017

Link zum Volltext

Verfügbarkeit prüfen

PAI-1, obesity, insulin resistance and risk of cardiovascular events

Thrombosis and haemostasis, 1997-07, Vol.78 (1), p.656

1997

Link zum Volltext

Verfügbarkeit prüfen

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Diabetes (New York, N.Y.), 1997-05, Vol.46 (5), p.860

1997

Link zum Volltext

Verfügbarkeit prüfen

Enhanced post‐clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1939-1941

2009

Link zum Volltext

Verfügbarkeit prüfen

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study

Arteriosclerosis, thrombosis, and vascular biology, 2007-10, Vol.27 (10), p.2250

2007

Link zum Volltext

Verfügbarkeit prüfen

Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha

The Journal of pathology, 2008-04, Vol.214 (5), p.574-583

2008

Link zum Volltext

Verfügbarkeit prüfen

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Arteriosclerosis, thrombosis, and vascular biology, 2002-05, Vol.22 (5), p.867

2002

Link zum Volltext

Verfügbarkeit prüfen

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

Journal of internal medicine, 2004-04, Vol.255 (4), p.448-456

2004

Link zum Volltext

Verfügbarkeit prüfen

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2671-2679

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men

American journal of physiology: endocrinology and metabolism, 2007-08, Vol.293 (2), p.E466-E474

2007

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator inhibitor type‐1 is an independent marker of metabolic disorders in young adults born small for gestational age

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2608-2613

2010

Link zum Volltext

Verfügbarkeit prüfen

O79 Rôle du CD28 dans le développement de l’état inflammatoire et des complications métaboliques associés à l’obésité

Diabetes & metabolism, 2013-03, Vol.39, p.A19-A19

2013

Link zum Volltext

Verfügbarkeit prüfen

O1 Facteurs prédictifs de la résistance au clopidogrel à 1 mois du syndrome coronarien aigu chez le patient diabétique

Diabetes & metabolism, 2012-03, Vol.38, p.A1-A1

2012

Link zum Volltext

Verfügbarkeit prüfen

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

Arteriosclerosis, thrombosis, and vascular biology, 2000-04, Vol.20 (4), p.1150

2000

Link zum Volltext

Verfügbarkeit prüfen

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort

British journal of haematology, 2005-01, Vol.128 (1), p.91-99

2005

Link zum Volltext

Verfügbarkeit prüfen

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Circulation (New York, N.Y.), 1997-08, Vol.96 (3), p.761-768

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 886

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(767)
Mit Volltextzugriff
(722)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

The CYP2C1917 allele is associated with better platelet response to clopidogrel in patients admitted for non‐ST acute coronary syndrome

inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes

Endothelial cell markers and the risk of coronary heart disease: The prospective epidemiological study of myocardial infarction (PRIME) study

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study

PAI-1, obesity, insulin resistance and risk of cardiovascular events

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Enhanced post‐clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control

Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study

Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism

Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men

Plasminogen activator inhibitor type‐1 is an independent marker of metabolic disorders in young adults born small for gestational age

O79 Rôle du CD28 dans le développement de l’état inflammatoire et des complications métaboliques associés à l’obésité

O1 Facteurs prédictifs de la résistance au clopidogrel à 1 mois du syndrome coronarien aigu chez le patient diabétique

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Suchergebnisse filtern